Perry Baromedical
我们是谁？
Perry Baromedical is a world leader in the manufacturing, installation and service of hyperbaric oxygen therapy (HBOT) systems. Hyperbaric chambers are FDA Class II medical devices used in the treatment of diving and altitude pressure related injuries, chronic wounds, post-radiation injuries, and neurological injuries among fourteen (14) FDA-approved medical indications. Perry has installed over 1,200 systems in healthcare facilities across 35 countries, and counts among its customers the most diagnostically and therapeutically advanced wound care clinical management services chains in the USA, the US NAVY and US AIR FORCE, as well as key reference hospitals in USA, UK, Canada, Australia, Mexico, Poland, Taiwan, Philippines, Vietnam, India and Kuwait. Perry has 60 years of experience in design innovation, stringent quality control, and superior after-sales service. Perry produces the world’s largest and most comfortable monoplace and dual-place HBOT chambers, with the most technologically advanced automatic control features, and the industry’s best safety record. Perry has multiple certified technical service teams available globally, including in the EU, APAC, LATAM, South Asia and Middle East regions.
我们的价值观
Perry Baromedical is a distinguished and internationally recognized brand name, with a history of more than 50 years of design innovation and quality manufacturing in its field. Perry is the only full line manufacturer of hyperbaric chambers in the industry, with its product line encompassing monoplace, dualplace, and multiplace systems. The Company sells its products to hospitals, private clinics, medical teaching institutions, critical access and children's hospitals, and burn institutes across the globe. Perry leads the HBO industry with a reputation for doing business with integrity and providing products of superior quality.
In its present form, Perry Baromedical is a young company. But its roots go back to 1956. We are proud of that heritage, and of the many milestones achieved.
